Pharma BD Deal Intelligence
Needham's Mike Matson: 10.6x EV/sales is 'well above the average orthopedics acquisition multiple of 3.1x.' BMO's Joanne Wuensch: 'the take-out price seems…
Needham's Mike Matson called the 10.6x EV/sales multiple 'well above the 3.1x ortho-acquisition average... but perhaps not shocking given MAKO's leadership.'…
Retrospective coverage acknowledged the deal was widely criticized at announcement ('even my customers were upset'), but argued the Mako investment ultimately…
Source summaries from our enrichment pipeline; follow links for originals.
All 7 sources with sentiment breakdown →
Stryker to acquire MAKO Surgical at $30/share cash (~$1.65B); platform diagnostics-enabled medtech (robotics) included for orthopedics franchise expansion.
Assessment window: 5yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Stryker Corporation / MAKO Surgical Corp. (this deal) | 2013 | $1.6B | 91 |
| Stryker Corporation / Wright Medical Group N.V. | 2019 | $5.4B | 81 |
| Stryker Corporation / Gaymar Industries | 2010 | $150M | 54 |
| Stryker Corporation / Trauson Holdings Company Limited | 2013 | $764M | 37 |
| Stryker Corporation / Inari Medical, Inc. | 2025 | $4.9B | — |
| Watson Pharmaceuticals (Actavis Inc.) / Actavis plc | 2012 | $5.9B | 97 |
| Kohlberg Kravis Roberts & Co. / PRA International (Genstar Capital) | 2013 | $1.3B | 91 |
← Browse all deals · How we score deals
More: 2013 deals · Stryker Corporation deals · Other deals